Dr. Siefferman distinguishes pain caused directly by a tumor from nerve pain resulting from cancer treatments like chemotherapy. Cancer-related pain is often compressive or mechanical, localized where a tumor presses on bone, organs, or nerves, or referred to adjacent regions. Chemotherapy-induced peripheral neuropathy causes widespread, symmetric symptoms such as burning, tingling, and balance issues. Determining whether tumor pressure, treatment-related nerve damage, or muscle guarding causes the pain guides whether therapy focuses on oncologic coordination, nerve-calming medications, or functional rehabilitation.
Chemotherapy can injure peripheral nerves and small nerve fibers, leading to persistent symptoms such as numbness, burning, and electrical shock sensations in the hands and feet. In this article, Dr. Siefferman explains that chemotherapy-induced peripheral neuropathy often involves secondary complications, including muscle guarding and central nervous system sensitization, which maintain pain after cancer treatment ends. A systematic evaluation examines nerve distribution, metabolic factors, and small fiber involvement. Care incorporates targeted neuropathic medications, physical therapy, and supportive therapies alongside cancer care teams.
Complex Regional Pain Syndrome often develops after an injury or nerve irritation, causing autonomic nervous system sensitization that extends beyond the original damage site. Standard imaging frequently fails to capture these diffuse changes, leading to misdiagnosis when symptoms like swelling, allodynia, and temperature fluctuations are evaluated separately. A complete evaluation incorporates clinical signs under the Budapest Criteria alongside procedures such as stellate ganglion or lumbar sympathetic blocks to confirm sympathetic involvement. In this article, Dr. Siefferman explains how systematic nervous system testing isolates the primary driver from secondary nervous system amplification.
The post explains how sympathetically maintained pain develops when the autonomic nervous system becomes engaged in a pain cycle, amplifying signals and spreading symptoms beyond the original injury. Through interconnected nerve ganglia and referred pain pathways, localized spinal or pelvic issues can produce widespread sensory and autonomic symptoms. Dr. Siefferman outlines a two-layered evaluation that calms nervous system sensitization while searching for the primary trigger driving the response. This approach addresses both broad autonomic overactivity and the underlying structural or inflammatory cause.
Neuropathic pain presents as burning, electric, or tingling sensations caused by nerve irritation, inflammation, or compression. Dr. Siefferman explains that standard imaging often looks normal because routine scans are taken while lying still, missing dynamic nerve traction during movement. Diagnostic nerve blocks help identify specific nerve pain generators by observing symptom changes during the numbing period. When symptoms are widespread, the workup expands to evaluate systemic drivers, including small fiber neuropathy, autoimmune conditions, and metabolic issues, ensuring that interventions target the underlying biological mechanism rather than just managing symptoms.
In this article, Dr. Siefferman describes a diagnosis-first, non-opioid approach to evaluating complex chronic pain. Long-term opioid use carries limitations such as tolerance, hyperalgesia, and poor fit for central sensitization or dysautonomia. Instead, care begins by identifying pain drivers through diagnostic mapping with selective nerve blocks. Once structural or nervous system sources are identified, targeted treatments range from regenerative options like prolotherapy and platelet-rich plasma to neuromodulation, sympathetic blocks, and rehabilitation therapies.
Dr. Jason W. Siefferman outlines a structured framework for managing complex chronic pain without relying primarily on opioids. The post explains that chronic pain often develops in distinct layers, where initial joint injuries lead to muscle guarding, nerve irritation, and heightened nervous system reactivity. To clarify these patterns, targeted diagnostic nerve blocks temporarily numb suspect structures, converting observation into precise anatomical evidence. Once the drivers are identified, treatment can combine regenerative therapies for structural instability, interventional procedures for nervous system sensitization, and movement retraining with pain psychology.
Diagnostic nerve blocks use local anesthetics to temporarily numb a specific nerve, joint, or tissue plane to help identify the primary source of complex chronic pain. By briefly silencing one pain signal, clinicians can evaluate whether a targeted structure is driving symptoms or if pain is being referred from an upstream source. Observing symptom changes during the numbing window, along with what occurs after the medication wears off, allows physicians to separate overlapping pain layers and assess central nervous system amplification.
In this article, Dr. Jason W. Siefferman compares steroid injections and regenerative medicine options such as prolotherapy and platelet-rich plasma. Steroid injections suppress active inflammation to reduce swelling and calm nerve irritation during acute flares. Conversely, regenerative therapies trigger a controlled inflammatory response to strengthen lax ligaments or compromised connective tissue. Dr. Siefferman explains that addressing underlying joint instability or hypermobility requires proper sequencing: calming heightened inflammation or nervous system sensitization must occur before introducing regenerative treatment to prevent triggering severe flares.
In this post, Dr. Siefferman describes how temporomandibular joint pain often extends beyond an isolated jaw problem. Joint laxity in hypermobility or Ehlers-Danlos syndrome can prompt masseter and temporalis muscle guarding to stabilize the jaw. Cervical spine dysfunction, upper neck muscle tension, trigeminal nerve irritation, and migraine activity can also generate strain across the facial and jaw muscles. Systemic inflammation from autoimmune conditions can worsen joint pain and laxity. Evaluating these head and neck mechanics together helps clarify the underlying driver of jaw pain.
